Final answer:
The Nonclinical Toxicology section includes information on a drug's cancer risk, as part of safety profiling from long-term carcinogenicity studies and does not typically contain details on ADME, inactive ingredients, or overdose treatments.
Step-by-step explanation:
The information found in the Nonclinical Toxicology section of a package insert typically includes data on a drug's potential to cause cancer risk through long-term carcinogenicity studies. This section is designed to provide information on the overall safety profile of the drug from nonclinical or preclinical studies, which may include toxicokinetics, safety pharmacology, and reproductive toxicology assessments. It does not typically cover how a drug is absorbed, metabolized, and eliminated from the body (ADME), which would be found in the Clinical Pharmacology section, nor does it list inactive ingredients or treatment protocols for overdose situations.